Elisabeth is an Investment Associate at Extantia, a climate-first VC firm committed to addressing decarbonization by investing in startups that have outsized potential to significantly reduce emissions and generate financial returns. At Extantia, she focuses on biotech solutions for climate, grid, geothermal, and data center decarbonization.

Before Extantia, she worked as a Strategy Consultant at Accenture to address utilities' and energy retailers' grid decarbonization challenges. She studied Biology and Biomedical Engineering at Carnegie Mellon University, where she researched neurological connectivity, oxygenator optimization, and virtual reality applications for addiction treatment.